Further functional studies, such as knockdown of OSMR or LOXL1 in GBM cell or stem cell models to examine effects on proliferation, apoptosis, and immune cell recruitment, or selective ablation of specific CAFs subpopulations in animal models to evaluate their causal roles in tumor progression and immune infiltration, are essential to confirm their functions. This evidence concerns the gene LOXL1 and glioblastoma.